China's first vaccine hustled to market as race to inoculate 1.3bn speeds up – The Citizen

China’s first vaccine hustled to market as race to inoculate 1.3bn speeds up
AFP
(FILES) In this file photo taken on December 9, 2020, a health worker prepares a syringe to inoculate a volunteer with a COVID-19 vaccine produced by China's Sinopharm during its trial at the Clinical Studies Center of the Cayetano Heredia University in Lima. (Photo by ERNESTO BENAVIDES / AFP)
The Sinopharm jab, which has surged ahead of a raft of Chinese competitors during Phase 3 trials, could signal a breakthrough in the battle to squash the pandemic in Asia.
China has granted “conditional” market approval to a Sinopharm vaccine with a reported 79 percent efficacy rate against Covid-19, health authorities said Thursday, a major stride towards inoculating the world’s largest population.

Related Keywords

Beijing ,China ,Wuhan ,Hubei ,Chinese ,Mao Junfeng ,Zhang Zhan ,Chen Shifei ,Zeng Yixin ,Pfizer ,National Health Commission ,National Medical Products Administration ,Consumer Goods Industry Department ,Vice Minister ,Lunar New ,பெய்ஜிங் ,சீனா ,சீன ,ஜாங் ஜான் ,ஃபைசர் ,தேசிய ஆரோக்கியம் தரகு ,நுகர்வோர் பொருட்கள் தொழில் துறை ,துணை அமைச்சர் ,சந்திர புதியது ,